Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2010-02-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm9014845PMID 20067290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.

  2009cited by this paper
• The butyrylcholinesterase knockout mouse is obese on a high-fat diet.

  2008cited by this paper
• Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.

  2008cited by this paper
• Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase.

  2008cited by this paper
• Discovery of a "true" aspirin prodrug.

  2008cited by this paper
• Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance.

  2007cited by this paper
• Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase

  2007cited by this paper
• Butyrylcholinesterase attenuates amyloid fibril formation in vitro.

  2006cited by this paper
• Human carboxylesterase isozymes: catalytic properties and rational drug design.

  2006cited by this paper
• Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.

  2005cited by this paper
• Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior.

  2004cited by this paper
• Regulation of attention and response to therapy in dementia by butyrylcholinesterase.

  2003cited by this paper
• Cholinergic function and Alzheimer's disease

  2003cited by this paper
• Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products*

  2003cited by this paper
• Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit

  2002cited by this paper
• Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine.

  2002cited by this paper
• Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine.

  2002cited by this paper
• Development of biologically active compounds by combining 3D QSAR and structure-based design methods

  2002cited by this paper
• Three‐dimensional structure of a complex of galanthamine (Nivalin®) with acetylcholinesterase from Torpedo californica: Implications for the design of new anti‐Alzheimer drugs

  2001cited by this paper
• Acetylcholinesterase inhibitors: SAR and kinetic studies on omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives.

  2001cited by this paper
• The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase.

  1999cited by this paper
• Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates.

  1999cited by this paper
• Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3H]DDF.

  1998cited by this paper
• Mechanism-based inhibitors of mammalian cholesterol esterase.

  1997cited by this paper
• Cocaine detoxification by human plasma butyrylcholinesterase.

  1997cited by this paper
• Asp7O in the peripheral anionic site of human butyrylcholinesterase.

  1996cited by this paper
• Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

  1994cited by this paper
• Butyrylcholinesterase‐rich neurons in rat brain demonstrated by a sensitive histochemical method

  1992cited by this paper
• Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.

  1992cited by this paper
• Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein

  1991cited by this paper
• Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.

  1991cited by this paper
• Carbamylation and Binding Constants for the Inhibition of Acetylcholinesterase by Physostigmine ( Eserine)

  1966cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer’s Disease

  2025cites this paper
• Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale

  2025cites this paper
• Isosorbide as a Molecular Glass: New Insights into the Physicochemical Behavior of a Biobased Diol

  2025cites this paper
• Expanding the reactive chemistry toolbox - warhead screening for covalent butyrylcholinesterase inhibitors.

  2025cites this paper
• Discovery of a highly selective BChE inhibitor with concomitant anti-neuroinflammatory activity for treating Alzheimer's disease.

  2025cites this paper
• Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease.

  2025cites this paper
• The Selectivity of Butyrylcholinesterase Inhibitors Revisited

  2025cites this paper
• Tunable nucleofugality in carbamoyl-bearing covalent cholinesterase inhibitors

  2025cites this paper
• Unnatural Phosphorus‐Containing α‐Amino Acids and Their N‐FMOC Derivatives: Synthesis and In Vitro Investigation of Anticholinesterase Activity

  2024cites this paper
• Natural products as a source of cholinesterase inhibitors

  2024cites this paper
• Design, synthesis of antipyrine-based Schiff bases and investigation of their cholinesterase and carbonic anhydrase activities by in vitro and in silico approaches

  2024cites this paper
• Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents

  2023cites this paper
• Exploring the enzyme inhibitory properties of Antarctic algal extracts

  2023cites this paper
• Real-time visualization of butyrylcholinesterase activity using a highly selective and sensitive chemiluminescent probe.

  2023cites this paper
• Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer's disease.

  2022cites this paper
• Design and Synthesis of Novel Dual Cholinesterase Inhibitors: In Vitro Inhibition Studies Supported with Molecular Docking

  2022cites this paper
• Discovery of carbamate-based Salicylic acid derivatives as novel Cholinesterase inhibitor

  2022cites this paper
• Synthesis of Benzothiazole Linked Triazole Conjugates and Their Evaluation Against Cholinesterase Enzymes

  2022cites this paper
• Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.

  2022cites this paper
• Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase

  2022cites this paper
• Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review.

  2021cites this paper
• Multivalent butyrylcholinesterase inhibitor discovered by exploiting dynamic combinatorial chemistry.

  2021cites this paper
• Butyrylcholinesterase - BuChE: A Potential Target for Development of Drugs for Alzheimer's Disease Treatment

  2020cites this paper
• Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screening.

  2020cites this paper
• Recent Advances in Virtual Screening for Cholinesterase Inhibitors.

  2020cites this paper
• Palladium-catalyzed regioselective cascade reaction of carbon dioxide, amines and allenes for the synthesis of functionalized carbamates

  2020cites this paper
• Bicyclic 5-5 Systems: Two Heteroatoms 1:1

  2020cites this paper
• Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model.

  2019cites this paper
• Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors

  2019cites this paper
• Inhibitory Effects and Kinetic-Docking Studies of Xanthohumol From Humulus lupulus Cones Against Carbonic Anhydrase, Acetylcholinesterase, and Butyrylcholinesterase

  2019cites this paper
• Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation

  2019cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease

  2018cites this paper
• Synthesis and characterisation of novel phenanthroline quinone derivatives and their evaluation as Alzheimer's disease therapeutic active ingredients

  2018cites this paper
• Synthesis and biological evaluation of phloroglucinol derivatives possessing α‐glycosidase, acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase inhibitory activity

  2018cites this paper
• The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.

  2018cites this paper
• Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.

  2018cites this paper
• Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.

  2018cites this paper
• Synthesis and biological evaluation of 8-hydroxy-2,7-naphthyridin-2-ium salts as novel inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).

  2017cites this paper
• Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.

  2017cites this paper
• Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.

  2017cites this paper
• Synthesis and the activity assessment of adamantylcontaining thiazolium inhibitors of butyrylcholinesterase

  2017cites this paper
• Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease

  2016influential citation
• Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase

  2016cites this paper
• Development of an in-vivo active reversible butyrylcholinesterase inhibitor

  2016cites this paper
• Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.

  2016cites this paper
• Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening.

  2016cites this paper
• (S)-Allyl Cysteine Derivatives as a New-type Cholinesterase Inhibitor

  2015cites this paper
• Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines

  2015cites this paper
• Molecular docking of different inhibitors and activators to butyrylcholinesterase

  2015cites this paper
• Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.

  2014cites this paper
• Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

  2014cites this paper
• Specific Cholinesterase Inhibitors: A Potential Tool to Assist in Management of Alzheimer Disease

  2014cites this paper
• Development of Cholinesterase Inhibitors using 1-Benzyl Piperidin-4-yl (α)-Lipoic Amide Molecules

  2014cites this paper
• Development of Cholinesterase Inhibitors Using (a)-Lipoic Acid-benzyl Piperazine Hybrid Molecules

  2013cites this paper
• NO-donating tacrine derivatives as potential butyrylcholinesterase inhibitors with vasorelaxation activity.

  2013cites this paper
• Synthesis of Selective Butyrylcholinesterase Inhibitors Coupled between α-Lipoic Acid and Polyphenols by Using 2-(Piperazin-1-yl)ethanol Linker

  2013cites this paper
• Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation.

  2012influential citation
• Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

  2012cites this paper
• Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as bulky inhibitors of acetylcholinesterase.

  2012cites this paper
• Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer.

  2012cites this paper
• The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.

  2012cites this paper
• New and unusual scaffolds in medicinal chemistry.

  2011cites this paper
• Alzheimer's disease: emerging trends in small molecule therapies.

  2011cites this paper
• Welcome Statement by the Chair

  2009cites this paper